화학공학소재연구정보센터
검색결과 : 19건
No. Article
1 Comparison of EMT mediated tyrosine kinase inhibitor resistance in NSCLC
Iderzorig T, Kellen J, Osude C, Singh S, Woodman JA, Garcia C, Puri N
Biochemical and Biophysical Research Communications, 496(2), 770, 2018
2 MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7
Ping W, Gao Y, Fan XW, Li WN, Deng Y, Fu XN
Biochemical and Biophysical Research Communications, 495(4), 2482, 2018
3 Vibsanin A sensitizes human acute myeloid leukemia cells to tyrosine kinase inhibitor-induced myeloid differentiation via activation of PKC and upregulation of Lyn
Shen X, Xing S, Zhang L, Wang FM, Ou HL, Shan YJ, Xiao H, Xiang GL, Wang XR, Zhao QS, Cong YW, Yu ZY
Biochemical and Biophysical Research Communications, 502(1), 110, 2018
4 Targeting of the BLT2 in chronic myeloid leukemia inhibits leukemia stem/progenitor cell function
Xiao MF, Ai HM, Li T, Rajoria P, Shahu P, Li XS
Biochemical and Biophysical Research Communications, 472(4), 610, 2016
5 Quantitation of sunitinib, an oral multitarget tyrosine kinase inhibitor, and its metabolite in urine samples by nonaqueous capillary electrophoresis time of flight mass spectrometry
Rodriguez J, Castaneda G, Munoz L, Villa JC
Electrophoresis, 36(14), 1580, 2015
6 Tyrosine kinase inhibitor Thiotanib targets Bcr-Abl and induces apoptosis and autophagy in human chronic myeloid leukemia cells
Fan JJ, Dong XC, Zhang WX, Zeng X, Li YB, Sun Y, Wang SF, Wang ZY, Gao HJ, Zhao WL, Ju DW
Applied Microbiology and Biotechnology, 98(23), 9763, 2014
7 miR-138-5p reverses gefitinib resistance in non-small cell lung cancer cells via negatively regulating G protein-coupled receptor 124
Gao Y, Fan XW, Li WN, Ping W, Deng Y, Fu XN
Biochemical and Biophysical Research Communications, 446(1), 179, 2014
8 Multiple Mechanisms Mediate Resistance to Sorafenib in Urothelial Cancer
Knievel J, Schulz WA, Greife A, Hader C, Lubke T, Schmitz I, Albers P, Niegisch G
International Journal of Molecular Sciences, 15(11), 20500, 2014
9 GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC)
Kawazoe H, Bilim VN, Ugolkov AV, Yuuki K, Naito S, Nagaoka A, Kato T, Tomita Y
Biochemical and Biophysical Research Communications, 423(3), 490, 2012
10 Determining the binding mode and binding affinity constant of tyrosine kinase inhibitor PD153035 to DNA using optical tweezers
Cheng CM, Lee YJ, Wang WT, Hsu CT, Tsai JS, Wu CM, Ou KL, Yang TS
Biochemical and Biophysical Research Communications, 404(1), 297, 2011